CoChat
Sign Up
Cited by 226Ovarian function and disordersDiabetes, Cardiovascular Risks, and LipoproteinsEndometriosis Research and Treatment

THE EPIDEMIOLOGY OF POLYCYSTIC OVARY SYNDROME

Solomon, Caren G.·1999·Endocrinology and Metabolism Clinics of North America
DOI 10.1016/s0889-8529(05)70069-4
Open this paper in CoChat — free account

Abstract

Polycystic ovary syndrome is a common problem affecting approximately 5% of women of reproductive age when defined by clinical features of anovulation and hyperandrogenism. Metabolic derangements associated with this condition may predispose to a range of diseases with attendant morbidity and mortality risks. In general, available data support significantly increased rates of type II diabetes mellitus, dyslipidemia, and endometrial cancer in PCOS that are not completely explained by obesity; data also suggest that rates of hypertension, gestational diabetes, and pregnancy-induced hypertension may likewise be increased, although the extent to which obesity mediates these risks is not clear. The increased prevalence of several cardiovascular risk factors in PCOS and limited cross-sectional data suggest that cardiovascular disease should be more likely in PCOS, but prospective data are lacking to confirm this supposition. Limited data have suggested an association between PCOS and ovarian cancer risk and require further study. The present data do not support an increased risk for breast cancer in this condition. Long-term prospective data are clearly needed to better delineate the nature and magnitude of disease risks associated with PCOS, with appropriate adjustment for associated obesity. Such information is a necessary background for understanding the role of established and emerging PCOS therapies, including oral contraceptives, intermittent progesterone, ovulation induction agents, and insulin sensitizers, in modifying such risks. In the meantime, close follow-up of women with PCOS and encouragement of lifestyle practices likely to reduce disease risks, such as regular exercise and weight control, should be standard practice.

Integrity signals

Registry

Crossref · 10.1016/s0889-8529(05)70069-4

Cites

81 of 81 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

1 of the 82 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Related

Authors
Solomon, C. G.
Affiliations
Harvard University (US)
Corresponding author
Solomon, Caren G.
ORCID
Solomon, Caren G.
Venue
Endocrinology and Metabolism Clinics of North America
Publisher
Elsevier BV
Published
1999-06
Volume
28
Issue
2
Pages
247-263
ISSN
0889-8529 (ISSN-L)
DOI
10.1016/s0889-8529(05)70069-4
OpenAlex
W4027708
Cited by
226
References
82
Citations by year
2026: 1 · 2024: 4 · 2023: 2 · 2022: 6 · 2021: 2 · 2020: 4 · 2019: 6 · 2018: 7 · 2017: 6 · 2016: 8 · 2015: 5 · 2014: 6 · 2013: 5 · 2012: 3
FWCI
12.20
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Endocrinology and Metabolism Clinics of North America (publishedVersion)
  • PubMed (publishedVersion)
Funders
American Heart Association
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
Keywords
polycystic ovary syndrome, anovulation, hyperandrogenism, type 2 diabetes, dyslipidemia, endometrial cancer, hypertension, gestational diabetes mellitus, cardiovascular risk, obesity, ovarian cancer risk, breast cancer risk, insulin sensitizers, ovulation induction, oral contraceptives, lifestyle intervention
MeSH terms
Cardiovascular Diseases, Female, Humans, Neoplasms, Polycystic Ovary Syndrome, Pregnancy, Pregnancy Complications, Risk Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review